Enlivex Therapeutics Ltd.
Utility Patent Applications
Last updated:
List of all Enlivex Therapeutics Ltd. patents 9 in total
| Status | Patent |
|---|---|
Application | Utility: COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: THERAPEUTIC POOLED BLOOD APOPTOTIC CELL PREPARATIONS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: EARLY APOPTOTIC CELLS FOR USE IN TREATING SEPSIS Filling date: 7 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: THERAPEUTIC APOPTOTIC CELLS FOR CANCER THERAPY Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Showing 1 to 9 of 9 patents.